Home › Asset managers › Fidelity › 2024-2025 › Against the board
Two kinds of vote are listed: a board-sponsored proposal Fidelity voted AGAINST or withheld on, and a shareholder proposal it voted FOR, with the board’s recommendation on it where the filings show one. A FOR vote on a proposal the board supported, or took no position on, is listed and labelled, but it is not a vote against the board. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.
Everything Only shareholder proposals it backed
6,122 proposals. The board-sponsored half of this list keeps the 6,000 proposals with the most funds behind them; the rest are in the interactive database. Every shareholder proposal it backed is listed in full.
| Company | Meeting | Proposal | Category | On the ballot from | Board recommended | Fidelity voted | Funds |
|---|---|---|---|---|---|---|---|
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Target Subscribers and Method of Subscription | Capital Structure | Board | AGAINST | 6 | |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Undertakings to be Made by the Relevant Entities in Respect of the Measures on the Dilution of the Company's Current Return by the Proposed Issuance of A Shares to Specific Target Subscribers | Capital Structure | Board | AGAINST | 6 | |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Validity Period of the Resolution Prior to the Issuance | Capital Structure | Board | AGAINST | 6 | |
| COSTAR GROUP INC. | June 26, 2025 | Proposal to approve, on an advisory basis, the Company's executive compensation. | Say-on-Pay | Board | AGAINST | 6 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Attribution of Profit and Loss During the Transition Period | Extraordinary Transactions | Board | AGAINST | 6 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Audit Report, Pro Forma Review Report and Valuation Report in Relation to the Transaction | Extraordinary Transactions | Board | AGAINST | 6 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Authorization of the Board and Its Authorized Persons to Handle All Related Matters | Extraordinary Transactions | Board | AGAINST | 6 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Completeness and Compliance of Implementation of Legal Proceedings of the Transaction and Validity of the Submitted Legal Documents | Extraordinary Transactions | Board | AGAINST | 6 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Confidentiality Measures and Confidentiality System Adopted for This Transaction | Extraordinary Transactions | Board | AGAINST | 6 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Description of the Basis and Fairness and Reasonableness of the Pricing of the Transaction | Extraordinary Transactions | Board | AGAINST | 6 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Distribution Arrangement of Undistributed Earnings | Extraordinary Transactions | Board | AGAINST | 6 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Fluctuation of the Company's Stock Price Before the Release of Information on This Transaction | Extraordinary Transactions | Board | AGAINST | 6 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Impact of Dilution of Current Returns on Major Financial Indicators, the Relevant Measures to be Taken and Commitment from Relevant Parties | Extraordinary Transactions | Board | AGAINST | 6 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Independence of Appraiser, the Validity of Hypothesis, the Relevance of Valuation Method and Purpose and Approach as Well as the Fairness of Pricing | Extraordinary Transactions | Board | AGAINST | 6 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Amount | Extraordinary Transactions | Board | AGAINST | 6 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Amount and Number of Issues | Extraordinary Transactions | Board | AGAINST | 6 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Manner and Target Subscribers | Extraordinary Transactions | Board | AGAINST | 6 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Type, Par Value and Listing Location | Extraordinary Transactions | Board | AGAINST | 6 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Lock-Up Period Arrangement | Extraordinary Transactions | Board | AGAINST | 6 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Overall Plan | Extraordinary Transactions | Board | AGAINST | 6 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Performance Commitment and Compensation Arrangement | Extraordinary Transactions | Board | AGAINST | 6 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Pricing Reference Date and Issue Price | Extraordinary Transactions | Board | AGAINST | 6 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Purchases and Sales of Assets in the Twelve Months Prior to the Transaction | Extraordinary Transactions | Board | AGAINST | 6 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Report (Draft) and Summary on Issuance of Shares and Acquisition by Cash as Well as Raising Supporting Funds and Related Party Transactions | Extraordinary Transactions | Board | AGAINST | 6 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Report on the Usage of Previously Raised Funds | Capital Structure | Board | AGAINST | 6 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Resolution Validity Period | Extraordinary Transactions | Board | AGAINST | 6 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Signing of Conditional Agreement to the Issuance of Shares and Acquisition by Cash as well as Performance Compensation Agreement | Extraordinary Transactions | Board | AGAINST | 6 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Target Assets | Extraordinary Transactions | Board | AGAINST | 6 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies With Article 18 and 21 of the Measures for the Continuous Supervision of ChiNext Listed Companies (Trial) and Article 8 of the Shenzhen Stock Exchange Listed Company Major Asset Restructuring Review Rules | Extraordinary Transactions | Board | AGAINST | 6 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies With Article 4 of Guidelines for the Supervision of Listed Companies No. 9 - Regulatory Requirements for Listed Companies to Plan and Implement Major Asset Restructuring | Extraordinary Transactions | Board | AGAINST | 6 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies with Articles 11 and 43 of the Measures for the Administration of Major Asset Restructuring of Listed Companies | Extraordinary Transactions | Board | AGAINST | 6 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies with the Relevant Provisions of the Administrative Measures for the Registration of Securities Issuance of Listed Companies | Extraordinary Transactions | Board | AGAINST | 6 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Constitute as Major Asset Restructuring and Does Not Constitute as Restructuring and Listing | Extraordinary Transactions | Board | AGAINST | 6 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Parties | Extraordinary Transactions | Board | AGAINST | 6 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Price and Payment Method | Extraordinary Transactions | Board | AGAINST | 6 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Use of Proceeds | Capital Structure | Board | AGAINST | 6 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve the Company's Plan for Issuance of Shares and Acquisition by Cash as Well as Raising Supporting Funds Complies with Relevant Laws and Regulations | Extraordinary Transactions | Board | AGAINST | 6 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve the Relevant Entity of Transaction Does Not Exist in Article 12 of Listed Company Supervision Guidelines No. 7 and Article 30 of the Guidelines for Self-regulatory Supervision No. 8 (Revised in 2023) | Extraordinary Transactions | Board | AGAINST | 6 | |
| Corcept Therapeutics Incorporated | June 10, 2025 | Election of Directors: David L. Mahoney | Director Elections | Board | WITHHOLD | 6 | |
| Corpay, Inc. | June 11, 2025 | Advisory vote to approve named executive officer compensation. | Say-on-Pay | Board | AGAINST | 6 | |
| Corpay, Inc. | June 11, 2025 | Elect Directors nominated by the Board of Directors for a one-year term: Joseph W. Farrelly | Director Elections | Board | AGAINST | 6 | |
| Corpay, Inc. | June 11, 2025 | Elect Directors nominated by the Board of Directors for a one-year term: Steven T. Stull | Director Elections | Board | AGAINST | 6 | |
| DAIICHIKOSHO CO. LTD. | June 20, 2025 | Elect Director Hoshi, Tadahiro | Director Elections | Board | AGAINST | 6 | |
| DEUTSCHE LUFTHANSA AG | May 6, 2025 | Elect Angela Titzrath to the Supervisory Board | Director Elections | Board | AGAINST | 6 | |
| DEVON ENERGY CORP. | June 4, 2025 | Advisory Vote to Approve Executive Compensation. | Say-on-Pay | Board | AGAINST | 6 | |
| DIVERSIFIED ENERGY CO. PLC | April 9, 2025 | Approve Remuneration Policy | Compensation | Board | AGAINST | 6 | |
| DOF GROUP ASA | July 26, 2024 | Elect Directors | Director Elections | Board | AGAINST | 6 | |
| DOF GROUP ASA | July 26, 2024 | Elect Members of Nominating Committee | Director Elections | Board | AGAINST | 6 | |
| DONGFANG ELECTRIC CORPORATION LTD. | March 14, 2025 | Approve Renewal of the General Mandate to Issue Shares Granted to the Board | Capital Structure | Board | AGAINST | 6 | |
| DOUGLAS ELLIMAN INC. | June 25, 2025 | Election of Directors: Wilson L. White | Director Elections | Board | WITHHOLD | 6 | |
| EMPIRE PETROLEUM CORP. | June 12, 2025 | Election of Directors: Michael R. Morrisett | Director Elections | Board | WITHHOLD | 6 | |
| ENDAVA PLC | December 12, 2024 | To approve the Directors' Remuneration Report contained in the 2024 Annual Report and Accounts. | Compensation | Board | AGAINST | 6 | |
| ENDAVA PLC | December 12, 2024 | To re-elect Mr. B Druskin as a Director. | Director Elections | Board | AGAINST | 6 | |
| ENDAVA PLC | December 12, 2024 | To re-elect Mr. T Smith as a Director. | Director Elections | Board | AGAINST | 6 | |
| ENDAVA PLC | December 12, 2024 | To re-elect Ms. K Hollister as a Director. | Director Elections | Board | AGAINST | 6 | |
| EOPTOLINK TECHNOLOGY INC. LTD. | May 15, 2025 | Approve Application of Bank Credit Lines and Provision of Guarantee | Capital Structure | Board | AGAINST | 6 | |
| ESSEX PROPERTY TRUST INC. | May 13, 2025 | Election of Directors: Keith R. Guericke | Director Elections | Board | AGAINST | 6 | |
| EUROFINS SCIENTIFIC SE | April 24, 2025 | Approve Remuneration Policy | Compensation | Board | AGAINST | 6 | |
| EUROFINS SCIENTIFIC SE | April 24, 2025 | Approve Remuneration Report | Compensation | Board | AGAINST | 6 | |
| EUROPRIS ASA | April 24, 2025 | Elect Martin Klafstad as Director | Director Elections | Board | AGAINST | 6 | |
| EUROPRIS ASA | April 24, 2025 | Elect Tom Vidar Rygh (Chair) as Director | Director Elections | Board | AGAINST | 6 | |
| EVE ENERGY CO. LTD. | October 9, 2024 | Approve Authorization of the Board to Handle All Related Matters | Compensation | Board | AGAINST | 6 | |
| EVE ENERGY CO. LTD. | October 9, 2024 | Approve Draft and Summary of Performance Shares Incentive Plan | Compensation | Board | AGAINST | 6 | |
| EVE ENERGY CO. LTD. | October 9, 2024 | Approve Methods to Assess the Performance of Plan Participants | Compensation | Board | AGAINST | 6 | |
| EVE ENERGY CO. LTD. | November 11, 2024 | Approve Adjustment of Performance Share Incentive Plan Shares Source | Compensation | Board | AGAINST | 6 | |
| EVgo Inc. | May 15, 2025 | Election of Directors: Joseph Esteves | Director Elections | Board | WITHHOLD | 6 | |
| EXPENSIFY INC. | June 13, 2025 | Election of Directors: David Barrett | Director Elections | Board | WITHHOLD | 6 | |
| FIRST FOUNDATION INC. | May 29, 2025 | Election of Directors: Benjamin Mackovak | Director Elections | Board | AGAINST | 6 | |
| FIRST FOUNDATION INC. | May 29, 2025 | Election of Directors: Elizabeth A. Pagliarini | Director Elections | Board | AGAINST | 6 | |
| FIRST FOUNDATION INC. | May 29, 2025 | Election of Directors: Henchy R. Enden | Director Elections | Board | AGAINST | 6 | |
| FIRST FOUNDATION INC. | May 29, 2025 | Election of Directors: Jacob P. Soneshine, J.D., CFA | Director Elections | Board | AGAINST | 6 | |
| FIRST FOUNDATION INC. | May 29, 2025 | Election of Directors: Max A. Briggs, CFP | Director Elections | Board | AGAINST | 6 | |
| FIRST FOUNDATION INC. | May 29, 2025 | Election of Directors: Mitchell M. Rosenberg | Director Elections | Board | AGAINST | 6 | |
| FOCUS MEDIA INFORMATION TECHNOLOGY CO. LTD. | May 21, 2025 | Amend the Company's Dividend Management System | Capital Structure | Board | AGAINST | 6 | |
| FOCUS MEDIA INFORMATION TECHNOLOGY CO. LTD. | June 25, 2025 | Approve Provision of Guarantee | Capital Structure | Board | AGAINST | 6 | |
| FOSHAN HAITIAN FLAVOURING & FOOD CO. LTD. | September 19, 2024 | Approve Authorization of the Board to Handle All Related Matters | Compensation | Board | AGAINST | 6 | |
| FOSHAN HAITIAN FLAVOURING & FOOD CO. LTD. | September 19, 2024 | Approve Draft and Summary on Employee Share Purchase Plan | Compensation | Board | AGAINST | 6 | |
| FOSHAN HAITIAN FLAVOURING & FOOD CO. LTD. | September 19, 2024 | Approve Management Measures for the Employee Share Purchase Plan | Compensation | Board | AGAINST | 6 | |
| FOXCONN INDUSTRIAL INTERNET CO. LTD. | June 19, 2025 | Approve to Appoint Auditor | Audit-related | Board | AGAINST | 6 | |
| FUYO GENERAL LEASE CO. LTD. | June 24, 2025 | Appoint Statutory Auditor Okubo, Eimei | Compensation | Board | AGAINST | 6 | |
| Fidelity National Financial, Inc. | June 11, 2025 | Approval of the redomestication of the Company from the State of Delaware to the State of Nevada by conversion. | Extraordinary Transactions | Board | AGAINST | 6 | |
| G MINING VENTURES CORP. | June 26, 2025 | Elect Director David Fennell | Director Elections | Board | AGAINST | 6 | |
| G MINING VENTURES CORP. | June 26, 2025 | Elect Director Louis Gignac, Sr. | Director Elections | Board | AGAINST | 6 | |
| GD POWER DEVELOPMENT CO. LTD. | September 5, 2024 | Approve Equity Transfer | Extraordinary Transactions | Board | AGAINST | 6 | |
| GEM CO. LTD. | May 19, 2025 | Approve Provision of Guarantee | Capital Structure | Board | AGAINST | 6 | |
| GENWORTH FINANCIAL INC. | May 22, 2025 | Advisory vote to approve named executive officer compensation. | Say-on-Pay | Board | AGAINST | 6 | |
| GFL ENVIRONMENTAL INC. | May 14, 2025 | Advisory Vote on Executive Compensation Approach | Compensation | Board | AGAINST | 6 | |
| GFL ENVIRONMENTAL INC. | May 14, 2025 | Elect Director Paolo Notarnicola | Director Elections | Board | WITHHOLD | 6 | |
| GODREJ CONSUMER PRODUCTS LTD. | August 7, 2024 | Approve Extension of Benefits of Godrej Consumer Products Limited Employees Stock Option Scheme 2024 to Eligible Employees of Group Company(ies) Including its Holding/Subsidiary/Associate Company(ies) | Compensation | Board | AGAINST | 6 | |
| GODREJ CONSUMER PRODUCTS LTD. | August 7, 2024 | Approve Godrej Consumer Products Limited Employees Stock Option Scheme 2024 | Compensation | Board | AGAINST | 6 | |
| GODREJ CONSUMER PRODUCTS LTD. | August 7, 2024 | Reelect Tanya Dubash as Director | Director Elections | Board | AGAINST | 6 | |
| GOERTEK INC. | July 15, 2024 | Approve Adjustment of Matters Relating to the Company's Homeland No. 7 Employee Share Purchase Plan | Compensation | Board | AGAINST | 6 | |
| GOERTEK INC. | May 22, 2025 | Approve Provision of Financial Assistance | Capital Structure | Board | AGAINST | 6 | |
| GOERTEK INC. | May 22, 2025 | Approve Provision of Guarantee | Capital Structure | Board | AGAINST | 6 | |
| GOLDWIND SCIENCE & TECHNOLOGY CO. LTD. | July 18, 2024 | Approve Provision of Full Guarantees and Issuance of Letters of Guarantee on Behalf of Majority-Owned Subsidiaries in South Africa | Capital Structure | Board | AGAINST | 6 | |
| GOLDWIND SCIENCE & TECHNOLOGY CO. LTD. | November 19, 2024 | Approve 2024 Restricted A Share Incentive Scheme (Draft) and its Summary | Compensation | Board | AGAINST | 6 | |
| GOLDWIND SCIENCE & TECHNOLOGY CO. LTD. | November 19, 2024 | Approve Implementation and Appraisal Management Measures of the 2024 Restricted Share Incentive Scheme | Compensation | Board | AGAINST | 6 | |
| GOLDWIND SCIENCE & TECHNOLOGY CO. LTD. | November 19, 2024 | Authorize Board to Handle Matters Related to the 2024 Restricted Share Incentive Scheme | Compensation | Board | AGAINST | 6 | |
| GOLDWIND SCIENCE & TECHNOLOGY CO. LTD. | June 26, 2025 | Elect Gao Jianjun as Director | Director Elections | Board | AGAINST | 6 | |
| GOSSAMER BIO INC. | June 25, 2025 | Approval of the amendment and restatement of the Company's 2019 Incentive Award Plan. | Compensation | Board | AGAINST | 6 |
← Previous Page 33 of 62 Next →
← Back to Fidelity 2024-2025 overview
Built October 25, 2026 from SEC Form N-PX filings.